Arteriovenous Malformations: Viewpoint—Surgery


Arteriovenous malformations (AVMs) are congenital vascular lesions that can develop anywhere in the central nervous system. The hemodynamic flow patterns within an AVM determine the probability of it hemorrhaging into the brain. The angioarchitecture of the AVM, its location in eloquent brain tissue, and its venous drainage pattern are important characteristics to consider when assessing surgical risk. Preoperative planning with noninvasive imaging modalities such as functional magnetic resonance imaging and diffusion tensor imaging, along with minimally invasive cerebral angiography, provides objective data that the cerebrovascular neurosurgeon can use to accurately determine the risks of surgical resection and discuss them with the patient. Additionally, preoperative embolization can also be a useful adjunct to AVM resection, making surgical resection safer. In situations where incomplete resection is performed, stereotactic radiosurgery can be a useful adjunct to the treatment plan. This chapter will address a multidisciplinary approach to AVM treatment planning, surgical tenets of AVM resection, and perioperative pitfalls.


Compute Tomography Angiography Diffusion Tensor Imaging Magnetic Resonance Angiography Digital Subtraction Angiography Preoperative Embolization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Davidson AS, Morgan MK. The embryologic basis for the anatomy of the cerebral vasculature related to arteriovenous malformations. J Clin Neurosci. 2011;18(4):464–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Di Rocco C, Tamburrini G, Rollo M. Cerebral arteriovenous malformations in children. Acta Neurochir (Wien). 2000;142(2):145–56; discussion 156–8.CrossRefGoogle Scholar
  3. 3.
    Pandey P, Marks MP, Harraher CD, Westbroek EM, Chang SD, Do HM, et al. Multimodality management of Spetzler-Martin Grade III arteriovenous malformations. J Neurosurg. 2012;116(6):1279–88.CrossRefPubMedGoogle Scholar
  4. 4.
    Stapf C. The rationale behind “A Randomized Trial of Unruptured Brain AVMs” (ARUBA). Acta Neurochir Suppl. 2010;107:83–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Mohr JP, Moskowitz AJ, Stapf C, Hartmann A, Lord K, Marshall SM, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41(8):e537–40.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Yashar P, Amar AP, Giannotta SL, Yu C, Pagnini PG, Liu CY, et al. Cerebral arteriovenous malformations: issues of the interplay between stereotactic radiosurgery and endovascular surgical therapy. World Neurosurg. 2011;75(5–6):638–47.CrossRefPubMedGoogle Scholar
  7. 7.
    Muñoz F, Clavel P, Molet J, Castaño C, de Teresa S, Solivera J, et al. Current management of arteriovenous malformations. Retrospective study of 31 cases and literature review. Neurocirugia (Astur). 2007;18(5):394–404.CrossRefGoogle Scholar
  8. 8.
    Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23(1):1–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34(5):e29–33.CrossRefPubMedGoogle Scholar
  10. 10.
    Stapf C, Labovitz DL, Sciacca RR, Mast H, Mohr JP, Sacco RL. Incidence of adult brain arteriovenous malformation hemorrhage in a prospective population-based stroke survey. Cerebrovasc Dis. 2002;13(1):43–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly Jr ES. Epidemiology and natural history of arteriovenous malformations. Neurosurg Focus. 2001;11(5):e1.CrossRefPubMedGoogle Scholar
  12. 12.
    Luo J, Lv X, Jiang C, Wu Z. Brain AVM characteristics and age. Eur J Radiol. 2012;81(4):780–3.CrossRefPubMedGoogle Scholar
  13. 13.
    Kondziolka D, Humphreys RP, Hoffman HJ, Hendrick EB, Drake JM. Arteriovenous malformations of the brain in children: a forty year experience. Can J Neurol Sci. 1992;19(1):40–5.PubMedGoogle Scholar
  14. 14.
    Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke. 2005;36(10):2099–104.CrossRefPubMedGoogle Scholar
  15. 15.
    Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1):1–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Hernesniemi JA, Dashti R, Juvela S, Väärt K, Niemelä M, Laakso A. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823–9; discussion 829–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Kim H, McCulloch CE, Johnston SC, Lawton MT, Sidney S, Young WL. Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol. 2010;171(12):1317–22.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004;35(7):1697–702.CrossRefPubMedGoogle Scholar
  19. 19.
    Laakso A, Dashti R, Seppänen J, Juvela S, Väärt K, Niemelä M, et al. Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery. 2008;63(2):244–53; discussion 253–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Wilkins RH. Natural history of intracranial vascular malformations: a review. Neurosurgery. 1985;16(3):421–30.CrossRefPubMedGoogle Scholar
  21. 21.
    McLaughlin MR, Kondziolka D, Flickinger JC, Lunsford S, Lunsford LD. The prospective natural history of cerebral venous malformations. Neurosurgery. 1998;43(2):195–200; discussion 200–201.CrossRefPubMedGoogle Scholar
  22. 22.
    Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King Jr JT. Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery. 1998;42(3):481–6; discussion 487–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Lv X, Wu Z, Li Y, Jiang C, Yang X, Zhang J. Cerebral arteriovenous malformations associated with flow-related and circle of Willis aneurysms. World Neurosurg. 2011;76(5):455–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Josephson CB, Bhattacharya JJ, Counsell CE, Papanastassiou V, Ritchie V, Roberts R, et al. Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology. 2012;79(6):500–7.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Zacharia BE, Vaughan KA, Jacoby A, Hickman ZL, Bodmer D, Connolly Jr ES. Management of ruptured brain arteriovenous malformations. Curr Atheroscler Rep. 2012;14(4):335–42.CrossRefPubMedGoogle Scholar
  28. 28.
    Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.CrossRefPubMedGoogle Scholar
  29. 29.
    Du R, Dowd CF, Johnston SC, Young WL, Lawton MT. Interobserver variability in grading of brain arteriovenous malformations using the Spetzler-Martin system. Neurosurgery. 2005;57(4):668–75; discussion 668–75.CrossRefPubMedGoogle Scholar
  30. 30.
    Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010;66(4):702–13; discussion 713.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Rodríguez-Hernández A, Kim H, Pourmohamad T, Young WL, Lawton MT. Cerebellar arteriovenous malformations: anatomical subtypes, surgical results, and increased predictive accuracy of the supplementary grading system. Neurosurgery. 2012;71(6):1111–24.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2011;114(3):842–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Cannestra AF, Pouratian N, Forage J, Bookheimer SY, Martin NA, Toga AW. Functional magnetic resonance imaging and optical imaging for dominant-hemisphere perisylvian arteriovenous malformations. Neurosurgery. 2004;55(4):804–12; discussion 812–4.CrossRefPubMedGoogle Scholar
  34. 34.
    Luessenhop AJ, Spence WT. Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. J Am Med Assoc. 1960;172:1153–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Liu HM, Huang YC, Wang YH. Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate. J Formos Med Assoc. 2000;99(12):906–13.PubMedGoogle Scholar
  36. 36.
    Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol. 2009;30(1):99–106.CrossRefPubMedGoogle Scholar
  37. 37.
    van Rooij WJ, Jacobs S, Sluzewski M, Beute GN, van der Pol B. Endovascular treatment of ruptured brain AVMs in the acute phase of hemorrhage. AJNR Am J Neuroradiol. 2012;33(6):1162–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Lv X, Wu Z, Jiang C, Li Y, Yang X, Zhang Y, et al. Complication risk of endovascular embolization for cerebral arteriovenous malformation. Eur J Radiol. 2011;80(3):776–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Lv X, Wu Z, Li Y, Yang X, Jiang C. Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation. Neurol Res. 2012;34(6):552–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Lv X, Wu Z, Jiang C, Li Y, Yang X, Zhang Y, et al. Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk. Interv Neuroradiol. 2010;16(2):127–32.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Xu F, Ni W, Liao Y, Gu Y, Xu B, Leng B, et al. Onyx embolization for the treatment of brain arteriovenous malformations. Acta Neurochir (Wien). 2011;153(4):869–78.CrossRefGoogle Scholar
  42. 42.
    Natarajan SK, Ghodke B, Britz GW, Born DE, Sekhar LN. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 2008;62(6):1213–25; discussion 1225–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Weber W, Kis B, Siekmann R, Jans P, Laumer R, Kühne D. Preoperative embolization of intracranial arteriovenous malformations with onyx. Neurosurgery. 2007;61(2):244–52; discussion 252–4.CrossRefPubMedGoogle Scholar
  44. 44.
    Yuki I, Kim RH, Duckwiler G, Jahan R, Tateshima S, Gonzalez N, et al. Treatment of brain arteriovenous malformations with high-flow arteriovenous fistulas: risk and complications associated with endovascular embolization in multimodality treatment. Clinical article. J Neurosurg. 2010;113(4):715–22.CrossRefPubMedGoogle Scholar
  45. 45.
    Viñuela F, Dion JE, Duckwiler G, Martin NA, Lylyk P, Fox A, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg. 1991;75(6):856–64.CrossRefPubMedGoogle Scholar
  46. 46.
    Jayaraman MV, Marcellus ML, Hamilton S, Do HM, Campbell D, Chang SD, et al. Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol. 2008;29(2):242–6.CrossRefPubMedGoogle Scholar
  47. 47.
    van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME. Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR Am J Neuroradiol. 2012;33(7):1299–304.CrossRefPubMedGoogle Scholar
  48. 48.
    Steinberg GK, Chang SD, Levy RP, Marks MP, Frankel K, Marcellus M. Surgical resection of large incompletely treated intracranial arteriovenous malformations following stereotactic radiosurgery. J Neurosurg. 1996;84(6):920–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Hashimoto T, Young WL. Anesthesia-related considerations for cerebral arteriovenous malformations. Neurosurg Focus. 2001;11(5):e5.CrossRefPubMedGoogle Scholar
  50. 50.
    Logvinova AV, Litt L, Young WL, Lee CZ. Anesthetic concerns in patients with known cerebrovascular insufficiency. Anesthesiol Clin. 2010;28(1):1–12.CrossRefPubMedGoogle Scholar
  51. 51.
    Gabarrós A, Young WL, McDermott MW, Lawton MT. Language and motor mapping during resection of brain arteriovenous malformations: indications, feasibility, and utility. Neurosurgery. 2011;68(3):744–52.CrossRefPubMedGoogle Scholar
  52. 52.
    Miller C, Mirski M. Anesthesia considerations and intraoperative monitoring during surgery for arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):153–64.CrossRefPubMedGoogle Scholar
  53. 53.
    Chalouhi N, Theofanis T, Jabbour P, Dumont AS, Gonzalez LF, Starke RM, et al. Safety and efficacy of intra-operative angiography in craniotomies for cerebral aneurysms and arteriovenous malformations: a review of 1093 consecutive cases. Neurosurgery. 2012;71(6):1162–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Luessenhop AJ, Ferraz FM, Rosa L. Estimate of the incidence and importance of circulatory breakthrough in the surgery of cerebral arteriovenous malformations. Neurol Res. 1982;4(3–4):177–90.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of NeurosurgerySUNY Upstate Medical UniversitySyracuseUSA
  2. 2.Department of NeurologyPrasat Neurological InstituteRajtheveeThailand

Personalised recommendations